Persistent arthropod-bite reactions (papular urticaria / strophulus)

Last Updated: 2026-11-19

Author(s): A. Navarini

ICD11: -

Publication History

Version 1

19 November 2026

Papular urticaria, strophulus, lichen urticatus, urticaria papulosa infantum; persistent arthropod-bite hypersensitivity reaction.

Recurrent, pruritic papules or papulovesicles caused by hypersensitivity to arthropod bites, predominantly in children but also in adults. This is an established clinical reaction pattern; the historical term “papular urticaria” does not denote true urticaria. Individual lesions persist for days to weeks.

  • Peak age 2–10 years; rare in infants.

  • Common in areas with high insect exposure.

  • Associated with atopy (asthma, atopic dermatitis).

  • Seasonal clustering (spring / summer), no sex differences.

  • Persistent bite reaction, classified dermatologically within the prurigo group.

  • Severe forms with vesiculation (‘strophulus bullosus’).

  • Allergic reaction (type I and type IV hypersensitivity) to insect saliva.

  • Common triggers: fleas, mosquitoes, bedbugs, mites.

  • SCRATCH factors (symmetry, clusters, Rover (pets have outdoor contact), paediatric age, chronology 24h).

  • Recurrent, intensely itchy, grouped papules (3–10 mm), often with a central punctum.

  • Different stages coexist.

  • Secondary excoriations from scratching, no systemic symptoms.

  • Diagnosis is usually clinical: recurrent crops of grouped, itchy papules or papulovesicles, often with a central punctum and an exposure-related pattern. The bite may be unnoticed and the responsible arthropod may remain unidentified. Individual lesions persist for days to weeks, unlike ordinary urticarial wheals.

  • A biopsy can support the diagnosis in atypical cases but is not diagnostic in isolation.

  • Papular eczema, including papular atopic dermatitis: a differential diagnosis, not a synonym. Look for xerosis, an eczematous background and a compatible chronic distribution; bite reactions can become secondarily eczematous.

  • Scabies: consider nocturnal itch, affected contacts, burrows and characteristic distribution; use dermoscopy or microscopy when indicated.

  • True urticaria: individual wheals usually disappear within 24 hours; persistent papules or papulovesicles favour an alternative diagnosis.

  • Exposed areas (limbs, buttocks, face), symmetrically distributed.

  • Areas covered by clothing are rarely affected.

  • Recurrent episodes during warmer months.

  • Association with pets, travel or insect infestation in the surroundings.

  • Improvement in winter is characteristic.

  • Parents often report unsuccessful treatment attempts for other diagnoses (e.g. scabies).

  • Dermal inflammation with eosinophils and oedema; epidermal spongiosis and vesiculation may occur. These findings overlap with eczematous and other hypersensitivity reactions and require clinical correlation.

  • No specific immunological markers.

  • Secondary infections (impetigo contagiosa).

  • Intense itching impairs sleep and quality of life.

  • Rarely, scarring after deep excoriations.

  • Self-limiting, usually with spontaneous remission by adolescence.

  • Excellent long-term prognosis.

  • Minimise insect exposure (mosquito nets, repellents, flea prevention in pets).

  • Identify and treat environmental infestation; the condition does not imply poor hygiene.

Avoid further bites: protective clothing and consistent flea control in pets are among the most important measures. Use an age-appropriate registered repellent exactly as labelled; avoid children’s hands, eyes, mouth and broken skin. Do not use oil of lemon eucalyptus / PMD under age three.

For symptom relief, topical glucocorticoids may be applied to affected sites early at symptom onset; calamine or menthol preparations and systemic antihistamines may relieve itching.

Reserve oral glucocorticoids for exceptional severe cases after clinical assessment. Topical or oral antibiotics may be considered for secondary infection.

The condition is usually self-limiting; relapses may occur even after months or years.

  1. CDC. Mosquitoes, Ticks, and Other Arthropods. CDC Yellow Book. 2025. Available online.

  2. Celiksoy MH, et al. Prevalence of atopic diseases in children with papular urticaria. Allergol Immunopathol (Madr). 2021;49(1):62-67. https://doi.org/10.15586/aei.v49i1.16

  3. Collado-Chagoya R, et al. Specific immunotherapy in patients with papular urticaria by Cimex lectularius: a pilot study. Eur Ann Allergy Clin Immunol. 2021;53(6):282-289. https://doi.org/10.23822/EurAnnACI.1764-1489.215

  4. Caffarelli C, et al. The many faces of pediatric urticaria. Front Allergy. 2023;4:1267663. https://doi.org/10.3389/falgy.2023.1267663

  5. Schettini N, et al. Urticaria: a narrative overview of differential diagnosis. Biomedicines. 2023;11(4):1096. https://doi.org/10.3390/biomedicines11041096

  6. Alraddadi MO, et al. Updates in papular urticaria: causes, diagnosis, and management – a systematic review. Int J Life Sci Pharma Res. 2023;13(1):L57-L65. https://doi.org/10.22376/ijlpr.2023.13.1.SP2.L57-L65

  7. Leung AKC, et al. Bed bug infestation: an updated review. Curr Pediatr Rev. 2024;20(2):137-149. https://doi.org/10.2174/1573396320666230406084801

  8. Rojo-Gutierrez MI, et al. Urticaria and other mimickers of urticaria. Front Allergy. 2025;5:1522749. https://doi.org/10.3389/falgy.2024.1522749

  9. Zuberbier T, et al. S3-Leitlinie Urtikaria, Teil 1: Klassifikation und Diagnostik (Adaptation der internationalen Guideline). J Dtsch Dermatol Ges. 2023;21(1):81-95. https://doi.org/10.1111/ddg.14906_g

  10. Oakley A, Koch K. Papular urticaria (Persistent insect bite reactions). DermNet New Zealand. Updated August 2021. (Available online).

  11. Singh S, Mann BK. Insect bite reactions (review article). Indian J Dermatol Venereol Leprol. 2013;79(2):151-164. (Including papular urticaria, historical reference). https://doi.org/10.4103/0378-6323.107631

  12. Papular urticaria. 2020. Available online.